GENCARO BUCINDOLOL HCL Trademark

Trademark Overview

On Saturday, November 12, 2016, a trademark application was filed for GENCARO BUCINDOLOL HCL with the United States Patent and Trademark Office. The USPTO has given the GENCARO BUCINDOLOL HCL trademark a serial number of 87234907. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 6, 2020. This trademark is owned by ARCA biopharma, Inc.. The GENCARO BUCINDOLOL HCL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations made in significant part of bucindolol hcl, for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields
gencaro bucindolol hcl

General Information

Serial Number87234907
Word MarkGENCARO BUCINDOLOL HCL
Filing DateSaturday, November 12, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 6, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 4, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of an image of heart with the words "GENCARO BUCINDOLOL HCL" to the right.
Goods and ServicesPharmaceutical preparations made in significant part of bucindolol hcl, for use in the treatment of diseases and disorders in the cardiovascular, vascular and hematology fields

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, November 18, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameARCA biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020
Party NameARCA biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWestminster, CO 80020

Trademark Events

Event DateEvent Description
Monday, July 6, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 6, 2020ABANDONMENT - NO USE STATEMENT FILED
Friday, December 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 5, 2019EXTENSION 5 GRANTED
Monday, December 2, 2019EXTENSION 5 FILED
Thursday, December 5, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 2, 2019TEAS EXTENSION RECEIVED
Friday, May 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 29, 2019EXTENSION 4 GRANTED
Wednesday, May 29, 2019EXTENSION 4 FILED
Wednesday, May 29, 2019TEAS EXTENSION RECEIVED
Tuesday, December 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 30, 2018EXTENSION 3 GRANTED
Friday, November 30, 2018EXTENSION 3 FILED
Friday, November 30, 2018TEAS EXTENSION RECEIVED
Friday, June 1, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 30, 2018EXTENSION 2 GRANTED
Wednesday, May 30, 2018EXTENSION 2 FILED
Wednesday, May 30, 2018TEAS EXTENSION RECEIVED
Saturday, December 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2017EXTENSION 1 GRANTED
Thursday, November 30, 2017EXTENSION 1 FILED
Thursday, November 30, 2017TEAS EXTENSION RECEIVED
Tuesday, May 30, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 4, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 4, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, February 18, 2017ASSIGNED TO EXAMINER
Saturday, November 19, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, November 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, November 16, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

bucindolol gencaro cardiovascular disorders vascular hematology fields diseases treatment made preparations significant